Gin Hwa Biotech Incorporation
Research Gin Hwa Biotech Incorporation (7806.TWO) on Bullrun: market cap TWD 1.62B, P/E 28.5, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7806.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 1.62B
- P/E28.5
- Dividend yield2.0%
- Financial periodQ2 2026
- RevenueTWD 145.93M
- Net incomeTWD 13.02M
- Free cash flow-TWD 33.14M
- Gross margin26.1%
Valuation Snapshot
latest market cap is TWD 1.62B; P/E is 28.5; dividend yield is 2.0%.
Peer valuation comparison
Latest P/E is 28.51x versus a Healthcare sector median of 21.8x (30.8% above).
Latest dividend yield is 2.02% versus a Healthcare sector median of 2.4% (15.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.62B | 28.5 | 1.8% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1 TWD, yield 2.0%.
About Gin Hwa Biotech Incorporation
Gin Hwa Biotech Incorporation manufactures and sells health supplements in Taiwan. The company offers nutritional supplements in various dosage forms, including soft gel encapsulations, tablets, capsules, liquids/ointments, powders, drop extracts, ready-to-drink, liquid sachets, pop rocks, tea bags, powder blends, ampoules, jellies, and other formats. Its products contain neuroboost, myorenew, dermaessence, cranbliss, and glycobalance ingredients.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Gin Hwa Biotech Incorporation's market cap?
Gin Hwa Biotech Incorporation's market capitalization is TWD 1.62B.
What is Gin Hwa Biotech Incorporation's P/E ratio?
Gin Hwa Biotech Incorporation's price-to-earnings (P/E) ratio is 28.5.
Does Gin Hwa Biotech Incorporation pay a dividend?
Gin Hwa Biotech Incorporation has a dividend yield of 2.0%.
What does Gin Hwa Biotech Incorporation do?
Gin Hwa Biotech Incorporation manufactures and sells health supplements in Taiwan. The company offers nutritional supplements in various dosage forms, including soft gel encapsulations, tablets, capsules, liquids/ointments, powders, drop extracts, ready-to-drink, liquid sachets, pop rocks, tea bags, powder blends, ampoules, jellies, and other formats. Its products contain neuroboost, myorenew, dermaessence, cranbliss, and glycobalance ingredients. Gin Hwa Biotech Incorporation was founded in 2019 and is based in Kaohsiung, Taiwan.